Sanara MedTech (SMTI) Accumulated Expenses (2010 - 2026)

Sanara MedTech has reported Accumulated Expenses for 16 years, with the latest figure at $9.1 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses rose 236.2% year-over-year to $9.1 million; the trailing twelve-month figure through Mar 2026 stood at $9.1 million (up 236.2% YoY), and the FY2025 full-year result was $11.8 million, up 420.1% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $9.1 million, down from $11.8 million in the prior quarter.
• The five-year high for Accumulated Expenses was $11.8 million in Q4 2025, with the low at $940337.0 in Q1 2022.
• Historically, Accumulated Expenses has averaged $6.1 million across 5 years, with a median of $6.3 million in 2022.
• Annual changes were most pronounced in 2022 — Accumulated Expenses surged 958.34% — and 2024, when it plunged 70.49%.
• Sanara MedTech's Accumulated Expenses stood at $2.1 million in 2022, then surged by 257.98% to $7.7 million in 2023, then sank by 70.49% to $2.3 million in 2024, then soared by 420.1% to $11.8 million in 2025, then decreased by 22.91% to $9.1 million in 2026.
• The last three Accumulated Expenses figures came in at $9.1 million (Q1 2026), $11.8 million (Q4 2025), and $10.9 million (Q3 2025), per Business Quant data.